CervoMed (CRVO) Debt Ratio (2010 - 2018)

CervoMed (CRVO) posted Debt Ratio of 0.02 for Q1 2018, down 21.64% sequentially from 0.02 in Q4 2017, and down 68.13% YoY from 0.05 in Q1 2017.

CervoMed (CRVO) Debt Ratio (2010 - 2018) Analysis & Trends

CervoMed has reported Debt Ratio for 9 years, with the latest figure at 0.02 in Q1 2018.

Quarterly Debt Ratio fell 68.13% year-over-year to 0.02 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was 0.02 (down 68.13% YoY) and the FY2017 annual result came in at 0.02, down 80.44% from the prior year.
Debt Ratio retreated to 0.02 in Q1 2018 per CRVO's latest filing, from 0.02 in the prior quarter.
Over five years, Debt Ratio peaked at 0.19 in Q4 2015 and troughed at 0.0 in Q3 2014.
A 5-year average of 0.06 and a median of 0.05 in 2017 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2014 and 2016: Debt Ratio plunged 99.89% in 2014, then sank 42.4% in 2016.
Over 5 years, Debt Ratio stood at 0.0 in 2014, then soared by 18770.95% to 0.19 in 2015, then tumbled by 42.4% to 0.11 in 2016, then sank by 80.44% to 0.02 in 2017, then declined by 21.64% to 0.02 in 2018.
According to Business Quant data, Debt Ratio over the past three periods registered 0.02, 0.02, and 0.02 for Q1 2018, Q4 2017, and Q3 2017 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.05
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.03
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.47
10	CervoMed	26.64 Mn	26.64 Mn	-	-

Download Data